IMA Advisory Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660 Buy
22
+7
+47% +$199 ﹤0.01% 1241
2026
Q1
$450 Hold
15
– – ﹤0.01% 876
2025
Q4
$490 Buy
+15
New +$484 ﹤0.01% 864

Other funds holding LKFT

IMA Advisory Services's LKFT Position: Q2 2026 in Review

IMA Advisory Services increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 47% in Q2 2026, buying an estimated $199 and bringing the position to 22 shares worth $660. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

IMA Advisory Services first reported a position in LKFT in Q4 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • IMA Advisory Services held 22 shares of Lakefront Biotherapeutics American Depositary Shares worth $660 as of Q2 2026.
  • IMA Advisory Services bought 7 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $199.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #1241 holding.
  • IMA Advisory Services first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.